Michel Laubie

2.2k total citations
91 papers, 1.8k citations indexed

About

Michel Laubie is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michel Laubie has authored 91 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 27 papers in Physiology and 21 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michel Laubie's work include Neuroscience of respiration and sleep (19 papers), Receptor Mechanisms and Signaling (19 papers) and Nitric Oxide and Endothelin Effects (14 papers). Michel Laubie is often cited by papers focused on Neuroscience of respiration and sleep (19 papers), Receptor Mechanisms and Signaling (19 papers) and Nitric Oxide and Endothelin Effects (14 papers). Michel Laubie collaborates with scholars based in France and United States. Michel Laubie's co-authors include Henri Schmitt, M Vincent, Tony J. Verbeuren, G. REMOND, Serge Simonet, H. Schmitt, Hubert Dabiré, Pierre Schiavi, Jean‐Jacques Descombes and J Roquebert and has published in prestigious journals such as Circulation Research, Brain Research and Hypertension.

In The Last Decade

Michel Laubie

88 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Laubie France 26 709 677 524 492 281 91 1.8k
Leoluca Criscione Switzerland 23 1.1k 1.5× 1.1k 1.7× 546 1.0× 712 1.4× 772 2.7× 39 2.6k
P. A. van Zwieten Netherlands 25 994 1.4× 712 1.1× 551 1.1× 631 1.3× 106 0.4× 109 2.2k
Margaret A. Petty United Kingdom 23 592 0.8× 522 0.8× 329 0.6× 219 0.4× 231 0.8× 70 1.7k
P. A. van Zwieten Netherlands 21 1.0k 1.4× 820 1.2× 426 0.8× 485 1.0× 74 0.3× 115 2.0k
Michael J. Antonaccio United States 28 1.0k 1.4× 573 0.8× 431 0.8× 1.1k 2.3× 139 0.5× 96 2.4k
R R Ruffolo United States 20 1.5k 2.2× 906 1.3× 666 1.3× 746 1.5× 123 0.4× 44 2.8k
James H. Ludens United States 23 2.0k 2.8× 1.1k 1.6× 479 0.9× 357 0.7× 107 0.4× 59 3.0k
Robert E. Stitzel United States 25 652 0.9× 552 0.8× 415 0.8× 212 0.4× 100 0.4× 84 1.8k
Kyuzo Aoki Japan 18 877 1.2× 431 0.6× 1.0k 1.9× 841 1.7× 249 0.9× 60 3.2k
R. Massingham Belgium 27 966 1.4× 614 0.9× 543 1.0× 316 0.6× 57 0.2× 86 2.1k

Countries citing papers authored by Michel Laubie

Since Specialization
Citations

This map shows the geographic impact of Michel Laubie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Laubie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Laubie more than expected).

Fields of papers citing papers by Michel Laubie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Laubie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Laubie. The network helps show where Michel Laubie may publish in the future.

Co-authorship network of co-authors of Michel Laubie

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Laubie. A scholar is included among the top collaborators of Michel Laubie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Laubie. Michel Laubie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dubuffet, Thierry, Olivier Müller, Jean‐Jacques Descombes, et al.. (1998). Synthesis and biological evaluation of new tetrahydronaphthalene derivatives as thromboxane receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(11). 1375–1380. 26 indexed citations
2.
Vayssettes‐Courchay, Christine, et al.. (1997). Central integration of the Bezold-Jarish reflex in the cat. Brain Research. 744(2). 272–278. 19 indexed citations
3.
Vayssettes‐Courchay, Christine, et al.. (1997). The central sympatho-inhibitory effect of 5,6-dihydroxy-2-dimethylaminotetralin (M7) is mediated by α2-adrenoceptors. European Journal of Pharmacology. 320(2-3). 151–159. 3 indexed citations
4.
Vayssettes‐Courchay, Christine, et al.. (1997). Recording of the saphenous vein compliance by an ultrasonic echo‐tracking device in the dog: effects of S 18149. British Journal of Pharmacology. 122(7). 1361–1366. 6 indexed citations
5.
Verbeuren, T.J., et al.. (1995). Evidence against the involvement of the nucleus tractus solitarii in the sympatholytic effect of 8-hydroxy-2-(di-n-propylamino) tetralin in the cat. European Journal of Pharmacology. 285(3). 299–304. 4 indexed citations
6.
Verbeuren, Tony J., et al.. (1993). Role of the nucleus tractus solitarii and the rostral depressive area in the sympatholytic effect of 8-hydroxy-2-(di-n-propylamino) tetralin in the cat. European Journal of Pharmacology. 242(1). 37–45. 6 indexed citations
7.
Simonet, Serge, et al.. (1992). Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney. European Journal of Pharmacology. 220(2-3). 161–171. 44 indexed citations
8.
Laubie, Michel, et al.. (1991). Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area. European Journal of Pharmacology. 192(3). 389–395. 10 indexed citations
9.
Dabiré, Hubert, et al.. (1991). S14063: a new potent 5-HT1A receptor antagonist devoid of β-adrenoceptor blocidng properties. European Journal of Pharmacology. 203(2). 323–324. 4 indexed citations
10.
Millan, Mark J., Hervé Canton, Jean‐Michel Rivet, et al.. (1991). S 14671: A novel naphthylpiperazane 5-HT1A agonist of high efficacy and exceptional in vivo potency. European Journal of Pharmacology. 203(2). 319–322. 8 indexed citations
11.
Verbeuren, T.J., et al.. (1990). Does 5-HT1A receptor activation cause renal vasodilatation?. European Journal of Pharmacology. 183(3). 666–666. 6 indexed citations
12.
Dabiré, Hubert, Michel Laubie, & Henri Schmitt. (1990). Hypotensive Effects of 5-HT1A Receptor Agonists on the Ventrolateral Medullary Pressor Area in Dogs. Journal of Cardiovascular Pharmacology. 15. S61–S67. 16 indexed citations
13.
Laubie, Michel, et al.. (1986). Renal Hemodynamic Effects of Tertatolol Compared with Those of Propranolol in the Conscious Dog. American Journal of Nephrology. 6(2). 20–24. 7 indexed citations
14.
Laubie, Michel, Pierre Schiavi, M Vincent, & Henri Schmitt. (1984). Inhibition of Angiotensin I-Converting Enzyme with S 9490. Journal of Cardiovascular Pharmacology. 6(6). 1076–1082. 47 indexed citations
15.
Laubie, Michel, Pierre Schiavi, Michel Vincent, & Henri Schmitt. (1984). Inhibition of Angiotensin I-Converting Enzyme with S 9490. Journal of Cardiovascular Pharmacology. 6(6). 1076–1082. 44 indexed citations
16.
Laubie, Michel, Henri Schmitt, M Vincent, & G. REMOND. (1977). Central cardiovascular effects of morphinomimetic peptides in dogs. European Journal of Pharmacology. 46(1). 67–71. 167 indexed citations
17.
Laubie, Michel & H. Schmitt. (1971). [New pharmacological method of treatment of peripheral arteritis. I. Circulatory effects of ET 495: 1-(2"-pyrimidyl)-4-(3',4'-methylenedioxybenzyl)piperazine].. PubMed. 24(3). 543–54. 1 indexed citations
18.
Duhault, J, et al.. (1969). [Pharmacological study of phenethyl-8-oxa-1-diaza-3,8-spiro(4,5)decanone-2 hydrochloride or fenspiride (JP 428)].. PubMed. 19(8). 1263–71. 1 indexed citations
19.
Laubie, Michel & H Schmitt. (1969). [Hemodynamic effects of ST 155, 2-(2,6 dichlorophenylamino)-2 imidazoline hydrochloride, in hypertensive dogs].. PubMed. 179(1). 23–5. 1 indexed citations
20.
Laubie, Michel, et al.. (1968). Effets hémodynamiques du propranolol chez le chien.. 175(2). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leoluca Criscione Breakdown of academic impact, for papers by P. A. van Zwieten Breakdown of academic impact, for papers by Margaret A. Petty Breakdown of academic impact, for papers by P. A. van Zwieten Breakdown of academic impact, for papers by Michael J. Antonaccio Breakdown of academic impact, for papers by R R Ruffolo Breakdown of academic impact, for papers by James H. Ludens Breakdown of academic impact, for papers by Robert E. Stitzel Breakdown of academic impact, for papers by Kyuzo Aoki Breakdown of academic impact, for papers by R. Massingham
Rankless by CCL
2026